Health Mar 15 Pfizer asks U.S. to approve a 4th COVID vaccine dose for seniors If the government approves the request, made by the company Tuesday, a key question would be how soon seniors would be advised to roll up their sleeves, given that cases currently are dropping.
Health Mar 01 Pfizer vaccine effective against severe COVID-19 for children between 5 and 11, CDC says A new government report shows Pfizer's COVID-19 vaccine gave children 5 and older strong protection against hospitalization and death even during the omicron surge.
Nation Feb 01 Pfizer asks FDA to allow COVID-19 vaccine for children under 5 Pfizer on Tuesday asked the U.S. to authorize extra-low doses of its COVID-19 vaccine for children under 5, potentially opening the way for the very youngest Americans to start receiving shots as early as March.
Health Jan 25 New Pfizer study to test omicron-specific vaccine Pfizer and BioNTech have begun studying a COVID-19 vaccine tweaked to match to the omicron variant in healthy adults.
Health Jan 20 Researchers test pig-to-human kidney transplant in donated body U.S. researchers are reporting the latest in a surprising string of experiments in the quest to save human lives with organs from genetically modified pigs.
Health Jan 10 Study offers reassurance on COVID shots, menstruation Researchers tracked nearly 4,000 U.S. women through six menstrual cycles and found a small and temporary change: The next period after a shot started about a day later than usual. But there was no change in the number of days…
Health Jan 05 CDC advisers endorse Pfizer COVID boosters for younger teens An influential government advisory panel is recommending COVID-19 boosters for younger teens. Boosters already are recommended for everyone 16 and older.
Health Jan 03 As omicron surges, FDA expands Pfizer boosters for more teens The U.S. is expanding COVID-19 boosters as it confronts the omicron surge. The Food and Drug Administration on Monday allowed extra Pfizer shots for children as young as 12.
Health Dec 16 CDC panel recommends Pfizer, Moderna vaccines over Johnson & Johnson shot due to blood clot risk Thursday's recommendation came after government advisers reviewed new safety data about rare but potentially life-threatening blood clots linked to J&J's shot.
Health Dec 16 WATCH: CDC panel examines J&J COVID-19 vaccine blood clot data, safety data for kids age 5-11 A government advisory panel is meeting Thursday to determine if any restrictions are needed for the Johnson & Johnson COVID-19 vaccine because of rare but serious blood clots.